Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Infertility 2

Interventions

Inositol 6follitropin alfa 4Glycoprotein Hormones, alpha Subunit 3follitropin beta 2Metformin 2Letrozole 2DLBS3233 2Clomiphene 2Chorionic Gonadotropin 2licogliflozin 1elagolix 1cetrorelix 1Urofollitropin 1Secretome 1Progesterone 1Oils 1Menotropins 1Leuprolide 1Lactalbumin 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Itraconazole 1Folic Acid 1Diosgenin 1Contraceptives, Oral 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Polycystic Ovary Syndrome × follitropin beta × Clear all
NCT01081639 2014-07-31

To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen

Merck KGaA, Darmstadt, Germany

Phase 3 Completed
34 enrolled

Infertility, Polycystic Ovary Syndrome

NCT00805935 2012-01-27

Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)

Ferring Pharmaceuticals

Phase 4 Completed
110 enrolled 22 charts

Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡